RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Austin, TX · Dallas, TX · +42 more sites
Prostate Cancer clinical trials in Irving, TX
7 recruiting prostate cancer studies with a site in Irving, TX.
RecruitingPhase 3NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Sponsor: Pfizer
Dallas, TX · +124 more sites
RecruitingPhase 1NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Sponsor: Exelixis
Austin, TX · Dallas, TX · +43 more sites
RecruitingPhase 1NCT07493512
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Sponsor: Amgen
Houston, TX · Irving, TX · +10 more sites
RecruitingPhase 1NCT04221542
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Amgen
Houston, TX · Irving, TX · +23 more sites
RecruitingPhase 1NCT07503808
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Sponsor: IDEAYA Biosciences
Austin, TX · Fort Worth, TX · Houston, TX · +12 more sites
RecruitingPhase 1 / Phase 2NCT07145255
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Sponsor: MBrace Therapeutics
Irving, TX · San Antonio, TX · +5 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.